Skip to main content

Next week, we’ll be attending ISPOR Europe 2022 (6 – 9th Nov) to connect, share and learn alongside industry peers from across the bio-pharma industry. We’re excited to share not only our capabilities as a high quality biostatistics supplier, but also our collaborative approach to building both client relationships and industry partnerships.

As a specialist CRO, we understand the power that a mutually beneficial partnership brings to the drug development life cycle. Combining specialised skills and capabilities through a partnership adds value to sponsors by increasing efficiency and work quality while reducing costs and delays in getting remedies to patients.

How do we build trust in a partnership?

Our partnerships reflect our values of integrity, collaboration and excellence and are reinforced through our B Corp accreditation. As a B Corp company, we adhere to the highest verified standards of social and environmental performance, transparency, and accountability. As a result, we’ve developed robust partnerships that are collaborative and transparent in nature, which in turn increases trust and promotes an equal, unified working relationship that lasts for years.

What does a partnership look like at Veramed?

As a biostatistics specialist, we give our partners access to a pool of over 300 Statisticians and Programmers with trial and study support from Phase 1 through to submission and beyond. In return, we’re able to level up our service offerings for clients, whether it be phase submission and strategic planning with Weatherden, next-generation automation and efficiency services with Domino, or patient-focused solutions with Sprout. Each partnership provides a unique offering that helps expand our service capabilities across all phases of the drug development life cycle.

Our mutually beneficial partnerships include:

Weatherdenensuring clients with the right strategy and support.

Weatherden provide support for the clinical aspects of trials including trial feasibility, clinical oversight, choosing a CRO and developing quality management systems. Our partnership combines that offering with our talent pool of 300+ expert Statisticians and Programmers, providing both parties with client referrals and collaboration.

Domino – increasing efficiency through automation & technology.

Domino are experts in maintaining and evolving an industry-leading data science and statistical computing environment. By partnering, we combine this expertise with our own expert clinical research analysis, evidence generation and clinical trial workflows to help increase efficiencies and quality of work for clients.

Sprout – patient engagement & regulatory support.

Sprout understands the patient experience and how to incorporate their needs into the drug development cycle. Our partnership gives Sprout access to 300+ Statisticians and Programmers and we in turn have access to experts in the patient experience, particularly COAs and PROs, and the clients that work with them. 

 

Interested in partnering with us? Download the flyer below to learn more and connect with our team at ISPOR 2022.

Attending ISPOR 2022 and unsure on which presentation to see? Anton Schönstein, Statistician II at Veramed, will be presenting a poster titled ‘Replication and extrapolation from RCTs to observational data to predict treatment effects‘ (MSR59) on the Tuesday, 11.15am -12.15pm. Learn more here.

Veramed